Doxorubicin, Paclitaxel, and Trastuzumab

About

Membership operator: AND

Therapies: 3

Therapies

Doxorubicin (tx:ncit:C456)

Paclitaxel (tx:ncit:C1411)

Trastuzumab (tx:ncit:C1647)

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
EMA (1) HER2-positive Invasive Breast Carcinoma Doxorubicin, Paclitaxel, Trastuzumab
EMA (1) ERBB2 amplification Invasive Breast Carcinoma Doxorubicin, Paclitaxel, Trastuzumab